Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic review

Imagem de Miniatura
Arquivos
art_TENGAN_Seroprevalence_of_hepatitis_C_virus_among_people_living_2016.PDF (749.84 KB)
Citações na Scopus
15
Tipo de produção
article
Data de publicação
2016
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Autores
Citação
BMC INFECTIOUS DISEASES, v.16, article ID 663, 8p, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Studies have shown that the immunosuppression induced by the human immunodeficiency virus (HIV) accelerates the natural history of liver disease associated with hepatitis C virus (HCV), with 3- to 5-fold higher odds of coinfected individuals developing cirrhosis. However, estimates of the seroprevalence of hepatitis C among people living with HIV/acquired immune deficiency syndrome (AIDS) (PLHA) in Latin America and the Caribbean (LAC) are widely variable. Methods: We performed a systematic review to estimate the seroprevalence of HCV among PLHA. We searched studies on HIV and HCV infections in LAC included in the PubMed, LILACS and Embase databases in December of 2014 with no time or language restrictions. The following combinations of search terms were used in the PubMed and Embase databases: (HIV OR Acquired Immunodeficiency Syndrome Virus OR AIDS OR HTLV OR Human Immunodeficiency Virus OR Human T Cell) AND (HCV OR HEPATITIS C OR HEPATITIS C VIRUS OR HEPACIVIRUS) AND (name of an individual country or territory in LAC). The following search terms were used in the LILACS database: (HIV OR AIDS OR Virus da Imunodeficiencia Humana) AND (HCV OR Hepatite C OR Hepacivirus). An additional 11 studies were identified through manual searches. A total of 2,380 publications were located, including 617 duplicates; the remaining articles were reviewed to select studies for inclusion in this study. Results: A total of 37 studies were selected for systematic review, including 23 from Brazil, 5 from Argentina, 3 from Cuba, 1 from Puerto Rico, 1 from Chile, 1 from Colombia, 1 from Mexico, 1 from Peru and 1 from Venezuela. The estimated seroprevalence of HCV infection varied from 0.8 to 58.5 % (mean 17.37; median 10.91), with the highest in Argentina and Brazil and the lowest in Venezuela and Colombia. Conclusions: Investigation of HCV infection among PLHA and of HIV infection among people living with HCV is highly recommended because it allows for better follow up, counseling and treatment of HIV/HCV-coinfected patients. Future studies with larger sample sizes are needed in both South and Central America to understand and address the risk factors associated with the acquisition of infection.
Palavras-chave
Hepatitis C, HCV, HIV, Coinfection, Seroprevalence, Latin America, Caribbean
URI
https://observatorio.fm.usp.br/handle/OPI/17904
Referências
  1. Abdala N, 2003, INT J STD AIDS, V14, P697, DOI 10.1258/095646203322387965
  2. Farias AA, 2013, T ROY SOC TROP MED H, V107, P432, DOI 10.1093/trstmh/trt043
  3. Alfonso AP, 2008, REV CUBA MED TROP, V60, P141
  4. Boyle MH, 1998, EVIDENCE BASED MENTA, V1, P37, DOI 10.1136/EBMH.1.2.37
  5. Brunetta DM, 2013, BRAZ J INFECT DIS, V17, P654, DOI 10.1016/j.bjid.2013.03.010
  6. Carmo RA, 2008, BRAZ J INFECT DIS, V12, P173, DOI 10.1590/S1413-86702008000300003
  7. Bello Corredor M, 2005, REV CUBA MED TROP, V57, P212
  8. de Carvalho F, 2006, REV PARA MED, V20, P11
  9. dos Santos EO, 2008, REV PARA MED, V22, P23
  10. EDELENYIPINTO M, 1993, MEM I OSWALDO CRUZ, V88, P305
  11. Fainboim H, 1999, J VIRAL HEPATITIS, V6, P53, DOI 10.1046/j.1365-2893.1999.t01-1-6120135.x
  12. TÁVORA Lara Gurgel Fernandes, 2013, Arq. Gastroenterol., V50, P277, DOI 10.1590/S0004-28032013000400007
  13. FOWKES FGR, 1991, BRIT MED J, V302, P1136
  14. Freitas SZ, 2014, REV INST MED TROP SP, V56, P517, DOI 10.1590/S0036-46652014000600011
  15. Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019
  16. Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909
  17. Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3
  18. Guimaraes R. A., 2010, Revista Brasileira de Medicina, V67, P296
  19. Hoyos-Orrego Alvaro, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P321, DOI 10.1590/S0036-46652006000600004
  20. HYAMS KC, 1992, J MED VIROL, V37, P127, DOI 10.1002/jmv.1890370210
  21. Jaspe RC, 2014, J MED MICROBIOL, V63, P1099, DOI 10.1099/jmm.0.067496-0
  22. Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x
  23. Librelotto CS, 2014, BRAZ J INFECT DIS, V18, P689, DOI 10.1016/j.bjid.2014.05.014
  24. Lincoln D, 2003, HIV Med, V4, P241, DOI 10.1046/j.1468-1293.2003.00152.x
  25. Loney P L, 1998, Chronic Dis Can, V19, P170
  26. Goncales NSL, 2007, BRAZ J INFECT DIS, V11, P22, DOI 10.1590/S1413-86702007000700008
  27. Mendes-Correa Maria Cassia J., 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P15, DOI 10.1590/S0036-46652001000100003
  28. Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005
  29. Mussi ADH, 2007, ACTA TROP, V104, P116, DOI 10.1016/j.actatropica.2007.08.001
  30. Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0
  31. Oliveira AB, 2012, ARCH VIROL, V157, P2411, DOI 10.1007/s00705-012-1435-3
  32. Pando MDP, 2004, AM J TROP MED HYG, V71, P153
  33. Pavan Maria Helena P., 2003, Braz J Infect Dis, V7, P253, DOI 10.1590/S1413-86702003000400005
  34. Pereira LMMB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-60
  35. Perez C, 2009, REV MED CHILE, V137, P641, DOI /S0034-98872009000500007
  36. Perez CM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-76
  37. Pineda JA, 2005, J ANTIMICROB CHEMOTH, V55, P417, DOI 10.1093/jac/dkh555
  38. de Carvalho FHP, 2009, REV SAUDE PUBL, V43, P133, DOI 10.1590/S0034-89102009000100017
  39. Prins J, 2002, INT J IMPOT RES, V14, P422, DOI 10.1038/sj.ijir.3900905
  40. Quan VM, 2009, AIDS CARE, V21, P7, DOI 10.1080/09540120802017610
  41. Quarleri Jorge F., 2007, Acta Gastroenterologica Latinoamericana, V37, P76
  42. Re V, 2008, ENFERM INFEC MICR CL, V26, P423, DOI 10.1157/13125639
  43. Rivas-Estilla AM, 2007, HEPATOL RES, V37, P311, DOI 10.1111/j.1872-034X.2007.00035.X
  44. Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762
  45. Rodriguez ME, 2005, CLIN MICROBIOL INFEC, V11, P764, DOI 10.1111/j.1469-0691.2005.01209.x
  46. Sampaio AS, 2009, ACTUALIZADIONES SID, V17, P12
  47. Santos KF, 2010, REV BRAS ANAL CLIN, V42, P21
  48. Segurado AC, 2004, AIDS PATIENT CARE ST, V18, P135, DOI 10.1089/108729104322994829
  49. Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042
  50. Simon D, 2014, EPIDEMIOL INFECT, V142, P2616, DOI 10.1017/S0950268814000041
  51. Solomon SS, 2008, JAIDS-J ACQ IMM DEF, V49, P327, DOI 10.1097/QAI.0b013e3181831e85
  52. Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3
  53. Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199
  54. Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608
  55. Tedaldi EM, 2003, CLIN INFECT DIS, V36, P363, DOI 10.1086/345953
  56. Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51
  57. THOMAS DL, 1995, MEDICINE, V74, P212, DOI 10.1097/00005792-199507000-00005
  58. Tovo Cristiane Valle, 2006, Arq. Gastroenterol., V43, P73, DOI 10.1590/S0004-28032006000200002
  59. Treitinger A, 1999, BRAZ J INFECT DIS, V3, P1
  60. Victoria MB, 2010, BRAZ J INFECT DIS, V14, P135, DOI 10.1590/S1413-86702010000200004
  61. Reiche EMV, 2008, INT J MOL MED, V21, P387
  62. WHO, GLOB HLTH OBS GHO DA
  63. Wolff FH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010494

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/47
Artigos e Materiais de Revistas Científicas - ODS/03